Streetbeat News

Revenues

ADMA

ADMA Biologics projects its FY24 revenue to exceed $355 million, surpassing the estimated $333.875 million. This forecast suggests a positive outlook for the company's financial performance in the upcoming fiscal year.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:15 pm

COLL

Collegium Pharmaceutical has reaffirmed its fiscal year 2024 guidance for product revenues, net of $580 million to $595 million, closely aligning with the estimated $582.249 million.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:13 pm

PBA

Pembina Pipeline (NYSE:PBA) reported Q1 earnings of $0.54 per share, surpassing the $0.53 estimate, marking a 20% increase from last year. However, their sales of $1.14B fell short of the $1.86B estimate, a 31.58% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:13 pm

HCAT

Health Catalyst projects its FY24 revenue to be between $304.0M and $312.0M, which is around the analyst estimate of $308.685M.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:11 pm

SG

Sweetgreen projects its FY24 revenue to be in the range of $660M-$675M, which is around the analyst estimate of $666.81M.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:10 pm

HCAT

Health Catalyst projects its Q2 2024 revenue to be in the range of $73.5M to $76.5M, which is around the analyst estimate of $75.554M.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:10 pm

LAW

CS Disco projects its FY24 revenue to be between $143M and $151M, which is around the analyst estimate of $149.239M.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:09 pm

AMPS

Altus Power has reaffirmed its fiscal year 2024 operating revenue expectations, projecting a range of $200 million to $222 million, with an estimated average of $214.31 million.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:09 pm

GROW

US Global Investors (NASDAQ:GROW) reported a 28.45% decrease in sales for Q3, with $2.59 million compared to $3.62 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:08 pm

FIGS

FIGS has updated its FY24 net revenues outlook, now expecting a change in the range of -2% to +2%, an improvement from its previous forecast of a mid-single-digit decline to flat revenues. This revision indicates a more optimistic view of the company's revenue trajectory for the fiscal year 2024.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:07 pm